REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,101,635 | -52.0% | 201,566 | -47.1% | 0.06% | -49.2% |
| Q3 2021 | $10,623,000 | +73.1% | 381,302 | +84.2% | 0.13% | +55.6% |
| Q2 2021 | $6,136,000 | +4.3% | 207,008 | -1.6% | 0.08% | -6.9% |
| Q1 2021 | $5,881,000 | -8.4% | 210,403 | -7.1% | 0.09% | -16.3% |
| Q4 2020 | $6,418,000 | -56.2% | 226,465 | -61.2% | 0.10% | -65.4% |
| Q3 2020 | $14,666,000 | -19.9% | 583,363 | -22.2% | 0.30% | -32.4% |
| Q2 2020 | $18,301,000 | +66.9% | 749,430 | +1.2% | 0.44% | +21.6% |
| Q1 2020 | $10,964,000 | +2.2% | 740,778 | +4.9% | 0.37% | +28.4% |
| Q4 2019 | $10,727,000 | +424.3% | 706,013 | +502.6% | 0.28% | +331.8% |
| Q1 2016 | $2,046,000 | -23.3% | 117,168 | +50.1% | 0.07% | -26.7% |
| Q4 2015 | $2,667,000 | +85.7% | 78,078 | +5.1% | 0.09% | +63.6% |
| Q3 2014 | $1,436,000 | -84.2% | 74,289 | -72.2% | 0.06% | -81.4% |
| Q2 2014 | $9,080,000 | +7.4% | 267,054 | -0.5% | 0.30% | +10.9% |
| Q1 2014 | $8,458,000 | – | 268,518 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |